200 related articles for article (PubMed ID: 15339061)
61. Pemetrexed disodium for the treatment of NSCLC: an update.
Hsu JY; Wakelee H
Drugs Today (Barc); 2008 Sep; 44(9):669-78. PubMed ID: 19137122
[TBL] [Abstract][Full Text] [Related]
62. Advances in the treatment of second-line non-small-cell lung cancer.
Hanna N
Lung Cancer; 2005 Oct; 50 Suppl 1():S15-7. PubMed ID: 16291425
[TBL] [Abstract][Full Text] [Related]
63. Pemetrexed (Alimta) in small cell lung cancer.
Socinski MA
Semin Oncol; 2005 Apr; 32(2 Suppl 2):S1-4. PubMed ID: 15818532
[TBL] [Abstract][Full Text] [Related]
64. [Lung cancer].
Ono A; Yamamoto N
Gan To Kagaku Ryoho; 2007 Mar; 34(3):367-73. PubMed ID: 17353626
[TBL] [Abstract][Full Text] [Related]
65. Phase I trials of pemetrexed.
Fossella FV; Gatzemeier U
Semin Oncol; 2002 Apr; 29(2 Suppl 5):8-16. PubMed ID: 12023787
[TBL] [Abstract][Full Text] [Related]
66. Phase II studies of pemetrexed in metastatic breast and gynecologic cancers.
Smith I
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):63-5. PubMed ID: 15655940
[TBL] [Abstract][Full Text] [Related]
67. Pemetrexed: single-agent and combination phase I study overview.
Boyer MJ; Rivory LP; Clarke SJ
Semin Oncol; 2002 Dec; 29(6 Suppl 18):18-23. PubMed ID: 12571806
[TBL] [Abstract][Full Text] [Related]
68. Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules.
Li KM; Rivory LP; Clarke SJ
Br J Cancer; 2007 Oct; 97(8):1071-6. PubMed ID: 17912246
[TBL] [Abstract][Full Text] [Related]
69. Pemetrexed: an active new agent for breast cancer.
O'Shaughnessy JA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):57-62. PubMed ID: 12571813
[TBL] [Abstract][Full Text] [Related]
70. Seeking new options for the treatment of small-cell lung cancer.
Socinski MA
Lung Cancer; 2005 Oct; 50 Suppl 1():S25-6. PubMed ID: 16291430
[TBL] [Abstract][Full Text] [Related]
71. Antimetabolites in the management of non-small cell lung cancer.
Budde LS; Hanna NH
Curr Treat Options Oncol; 2005 Jan; 6(1):83-93. PubMed ID: 15610718
[TBL] [Abstract][Full Text] [Related]
72. Pemetrexed in pancreatic cancer.
Kindler HL
Semin Oncol; 2002 Dec; 29(6 Suppl 18):49-53. PubMed ID: 12571811
[TBL] [Abstract][Full Text] [Related]
73. Pemetrexed in pancreatic cancer.
Seitz JF; Dahan L; Ries P
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):43-7. PubMed ID: 15655936
[TBL] [Abstract][Full Text] [Related]
74. Pemetrexed in bladder, head and neck, and cervical cancers.
Paz-Ares L; Ciruelos E; García-Carbonero R; Castellano D; Lopez-Martín A; Cortés-Funes H
Semin Oncol; 2002 Dec; 29(6 Suppl 18):69-75. PubMed ID: 12571815
[TBL] [Abstract][Full Text] [Related]
75. The role of pemetrexed in the treatment of colorectal cancer.
Hochster H
Semin Oncol; 2002 Dec; 29(6 Suppl 18):54-6. PubMed ID: 12571812
[TBL] [Abstract][Full Text] [Related]
76. Pemetrexed in gastric cancer.
Sobrero A; Caprioni F; Fornarini G; Mammoliti S; Comandini D; Baldo S; Decian F
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):51-5. PubMed ID: 15655938
[TBL] [Abstract][Full Text] [Related]
77. The role of chemotherapy and radiation in the treatment of locally advanced non-small cell lung cancer (NSCLC).
Wagner TD; Yang GY
Curr Drug Targets; 2010 Jan; 11(1):67-73. PubMed ID: 19839925
[TBL] [Abstract][Full Text] [Related]
78. Pemetrexed safety and dosing strategy.
Niyikiza C; Hanauske AR; Rusthoven JJ; Calvert AH; Allen R; Paoletti P; Bunn PA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):24-9. PubMed ID: 12571807
[TBL] [Abstract][Full Text] [Related]
79. Preclinical and clinical studies with combinations of pemetrexed and gemcitabine.
Adjei AA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):30-4. PubMed ID: 12571808
[TBL] [Abstract][Full Text] [Related]
80. Pemetrexed disodium.
Gibbs D; Jackman A
Nat Rev Drug Discov; 2005 May; Suppl():S16-7. PubMed ID: 15962527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
